
Streptococcus pyogenes (Group A Streptococcus [GAS]) requires flexible metabolic regulation to adapt to diverse host environments; however, its physiological responses to lactose and glycerol remain poorly characterized compared with glucose. In this study, we analyzed three representative serotype M1 GAS strains—the M1global strain 5448, the ancestral M1 strain SF370, and SP1380 as a representative of the recently emerged M1UK lineage. Glycerol consistently suppressed lactose-dependent growth across all strains, whereas glycerol-dependent respiratory activity was observed in 5448 and SF370 but was absent in SP1380. RNA-seq analysis of strain 5448 revealed no significant transcriptional changes upon glycerol supplementation, indicating that this inhibitory effect likely occurs through a nontranscriptional mechanism. In contrast, lactose supplementation induced distinct transcriptional programs compared with glucose, including coordinated expression changes gene sets regulated by carbohydrate-responsive transcription factors (CcpA, MalR, and NanR) and by the virulence regulator Mga and the stress-response regulator Rgg. Together, these findings identify a previously unrecognized layer of carbon source-dependent metabolic regulation and growth control in GAS.
Clostridioides difficile infection remains a leading cause of healthcare-associated diarrhea, and treatment options remain constrained by frequent recurrence and disruption of the intestinal microbiota. Natural products with selective antibacterial activity may provide new therapeutic opportunities for C. difficile. In this study, the pentacyclic triterpene maslinic acid, a naturally occurring compound abundant in olives and olive-derived products, was evaluated for its antibacterial activity against C. difficile. Maslinic acid inhibited a diverse panel of clinical isolates, including hypervirulent strains, with MIC values of 8–16 μg/mL while exhibiting substantially weaker activity against representative commensal gut bacteria. Time-kill studies demonstrated complete elimination of detectable C. difficile within 2 h of treatment, indicating rapid bactericidal activity. Additionally, its antibacterial potency was preserved when tested at high bacterial inoculum and following prolonged exposure to simulated gastric and intestinal fluids, suggesting favorable stability under gastrointestinal conditions. Maslinic acid also showed no cytotoxicity to Caco-2 cells at concentrations substantially exceeding its MICs. Mechanistic studies further indicated that maslinic acid preferentially interfered with protein and lipid biosynthetic pathways without evidence of membrane disruption. Moreover, evaluation of structurally related pentacyclic triterpenes identified several analogs with comparable activity with maslinic acid and highlighted structural features associated with antibacterial potency. Collectively, these findings identify maslinic acid as a selective, rapidly bactericidal natural product with characteristics that support its continued investigation as a potential therapeutic candidate for C. difficile infections.
Accurate antimicrobial susceptibility testing (AST) is essential for guiding effective therapy and monitoring antibiotic resistance, particularly for Pseudomonas aeruginosa, a pathogen noted for its intrinsic and adaptive resistance mechanisms. Mueller–Hinton agar (MHA) is the standard medium for AST; however, variations in its composition among commercial brands can significantly affect test outcomes. This study evaluated the influence of five different commercial MHAs (HiMedia, Merck, Condalab, Quelab, and Sigma) on the antibiogram results of imipenem, ciprofloxacin, and gentamicin against both standard (P. aeruginosa ATCC 15442) and 50 clinical isolates. Three inoculation methods, swab, pour plate, and double-layer, were compared with identify the most reproducible approach. Inductively coupled plasma mass spectrometry (ICP-MS) was used to quantify divalent cations (Ca2+, Mg2+, Zn2+, Mn2+, Fe2+) in each medium, and microscopic examination assessed gel microstructure. The double-layer method demonstrated the lowest coefficient of variation, indicating superior reproducibility compared with the swab and pour plate techniques. Significant differences were observed among media in inhibition zone diameters, with Quelab and Condalab producing consistently smaller zones (p<0.05). Cation analysis revealed wide variability, with calcium and magnesium levels differing up to fourfold across brands and being associated with differences in antibiotic activity, particularly for gentamicin and ciprofloxacin. Microscopic evaluation revealed minor gel-structure variations without measurable impact on antibiotic diffusion. Susceptibility profiles also differed among MHA brands. These findings highlight the potential importance of medium composition, particularly cation concentration, in the variability of AST results. Standardization and rigorous quality control of commercial MHAs are essential to ensure reliable, reproducible, and clinically meaningful susceptibility testing.
Incomplete bacterial eradication despite appropriate antimicrobial therapy contributes to the progression of some bacterial infections toward chronic or recurrent disease. Beyond genetically encoded antimicrobial resistance, bacterial persistence may be sustained by phenotypically tolerant subpopulations, including persister cells, together with biofilm-associated growth. These states arise within heterogeneous microenvironments shaped by antimicrobial exposure, immune pressure, nutrient and oxygen limitation, and tissue injury. Failure of inflammation to resolve effectively may further promote persistent inflammatory signaling, impaired phagocytic function, localized hypoxia, and extracellular matrix disruption, thereby creating conditions that favor bacterial survival and biofilm stability. This review critically examines the mesenchymal stem cell–derived secretome as a potential host-directed adjunct for persistent and biofilm-associated bacterial infections. Rather than reiterating its antimicrobial, immunomodulatory, and regenerative properties, we integrate direct antibiofilm and antimicrobial evidence with indirect host-mediated mechanisms involving NF-κB modulation, proresolving macrophage responses, efferocytosis, and tissue repair. These actions may converge on host–pathogen niches that sustain bacterial persistence. However, direct evidence that MSC-secretome reduces persister frequency, reverses bacterial dormancy, or eliminates persister populations remains limited. By distinguishing experimentally demonstrated effects from mechanistically inferred actions, this review proposes a host–pathogen ecological framework for evaluating MSC-secretome in bacterial persistence. Current evidence remains predominantly preclinical. Key priorities include improved product standardization and potency assessment, validation in physiologically relevant chronic infection models, and clearer definition of dosing, delivery, and combination strategies with conventional antimicrobials.